Atea Pharmaceuticals, Inc. balance sheet

At the end of fiscal 2021, Atea Pharmaceuticals, Inc. had total assets of $773m, total liabilities of $62.8m and shareholders' equity of $710m. It held $764m in cash against $0 of debt: net cash of $764m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Atea Pharmaceuticals, Inc.: balance sheet, annual
Fiscal year	2020Dec 2020	2021Dec 2021
Cash and equivalents	850	764
Total current assets	863	772
Total assets	864	773
Accounts payable	0	5
Deferred revenue (current)	301	—
Total current liabilities	316	57
Total debt	0	0
Total liabilities	316	63
Shareholders' equity	548	710
Net debt (negative = net cash)	−850	−764
Shares outstanding	82m	83m

US$ millions unless shown otherwise. Fiscal quarters.

Atea Pharmaceuticals, Inc.: balance sheet, quarterly
Quarter	2021 Q1Mar 2021	2021 Q2Jun 2021	2021 Q3Sept 2021	2021 Q4Dec 2021
Receivables	—	50	—	—
Total current assets	840	871	843	772
Total assets	841	872	844	773
Accounts payable	4	11	22	5
Deferred revenue (current)	235	225	192	—
Total current liabilities	254	274	262	57
Total liabilities	254	274	262	63
Shareholders' equity	586	598	581	710
Shares outstanding	83m	83m	83m	83m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Atea Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Atea Pharmaceuticals, Inc.